Cargando…

Immunohistochemical subtype and its relationship with 5-year overall survival in breast cancer patients

BACKGROUND: Breast cancer (BC) is the malignant tumour that has been most frequently diagnosed, being the second most common cancer worldwide and the most frequent in women. OBJECTIVE: To analyse the probability of 5-year overall survival according to age, stage of disease, immunohistochemical subty...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aldaz-Roldán, Pablo, Pardo-Vásquez, Diego F, Chamba-Morales, Geanella N, Aguirre-Reyes, Daniel F, Castillo-Calvas, Johana M, Noblecilla-Arévalo, Gabriela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129377/ https://www.ncbi.nlm.nih.gov/pubmed/37113711 http://dx.doi.org/10.3332/ecancer.2023.1509

Ejemplares similares

No Overall Survival Difference in the Immunotherapy Era for Rare Subtypes of Melanoma
por: Safi, Mohammed, et al.
Publicado: (2021)

Immunohistochemical characterization of subtypes of male breast carcinoma
por: Ge, Yimin, et al.
Publicado: (2009)

New Immunohistochemical Markers for Pleural Mesothelioma Subtyping
por: Di Stefano, Iosè, et al.
Publicado: (2023)

Angiogenin Upregulation Independently Predicts Unfavorable Overall Survival in Proneural Subtype of Glioblastoma
por: Hu, Ji-liang, et al.
Publicado: (2019)

Immunohistochemical Subtypes of Breast Cancer: Correlation with Clinicopathological and Radiological Factors
por: Sohn, Yu-Mee, et al.
Publicado: (2016)

Immunohistochemical Expression of MMP-9 and E-Cadherin in subtypes of Ameloblastoma
por: Farhan, Farah, et al.
Publicado: (2022)

Subtype classification of malignant lymphoma using immunohistochemical staining pattern
por: Hashimoto, Noriaki, et al.
Publicado: (2022)

Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs
por: Sisa, Ivan, et al.
Publicado: (2021)

Sex differences in esophageal cancer overall and by histological subtype
por: Stabellini, Nickolas, et al.
Publicado: (2022)

Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer
por: van Uden, D. J. P., et al.
Publicado: (2019)

Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients
por: Sannino, Giuseppina, et al.
Publicado: (2019)

Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer
por: van Uden, Dominique J. P., et al.
Publicado: (2019)

Etiopathogenetic Factors of Hepatocellular Carcinoma, Overall Survival, and Their Evolution over Time—Czech Tertiary Center Overview
por: Hříbek, Petr, et al.
Publicado: (2022)

Immunohistochemical profile of uterine leiomyomas; a comparison between different subtypes
por: Azimpouran, Mahzad, et al.
Publicado: (2016)

Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics
por: Birkman, Eva-Maria, et al.
Publicado: (2017)

Immunohistochemical Expression of Androgen Receptors (AR) in Various Breast Cancer Subtypes
por: Ismael, Nour El Hoda S., et al.
Publicado: (2019)

Rare Breast Malignancy Subtypes: A Cytological, Histological, and Immunohistochemical Correlation
por: Kaur, Manmeet, et al.
Publicado: (2019)

Clinical, histopathologic, subtype, and immunohistochemical analysis of jaw phosphaturic mesenchymal tumors
por: Li, Dongmei, et al.
Publicado: (2020)

Subtyping of high grade serous ovarian carcinoma: histopathological and immunohistochemical approach
por: Khashaba, Marwa, et al.
Publicado: (2022)

Immunohistochemical Subtypes of The Breast Cancer in The Ultrasound and Clinical Aspect – Literature Review
por: Dobruch-Sobczak, Katarzyna, et al.
Publicado: (2022)

Highlighting the immunohistochemical differences of malignant mesothelioma subtypes via case presentations
por: Sejben, Anita, et al.
Publicado: (2023)

Revisiting the impact of age and molecular subtype on overall survival after radiotherapy in breast cancer patients
por: Mao, Jian-Hua, et al.
Publicado: (2017)

Signature based on molecular subtypes of deoxyribonucleic acid methylation predicts overall survival in gastric cancer
por: Bian, Jin, et al.
Publicado: (2020)

Association of immunohistochemical markers of tumor subtype with response to neoadjuvant chemotherapy and survival in patients with muscle-invasive bladder cancer
por: Razzaghdoust, Abolfazl, et al.
Publicado: (2021)

Differences in breast carcinoma immunohistochemical subtypes between immigrant Arab and European women
por: Preat, Fanny, et al.
Publicado: (2014)

Immunohistochemical Expression and Localization of Somatostatin Receptor Subtypes in Androgen Ablated Prostate Cancer
por: Mazzucchelli, Roberta, et al.
Publicado: (2010)

A Histomorphologic Grading System That Predicts Overall Survival in Diffuse Malignant Peritoneal Mesothelioma With Epithelioid Subtype
por: Valente, Kari, et al.
Publicado: (2016)

Increased LGALS3 expression independently predicts shorter overall survival in patients with the proneural subtype of glioblastoma
por: He, Xia, et al.
Publicado: (2019)

Inflammatory aging clock: A cancer clock to characterize the patients’ subtypes and predict the overall survival in glioblastoma
por: Zhu, Lei, et al.
Publicado: (2022)

The Immune Subtype Contributes to Distinct Overall Survival for Ovarian Cancer Patients With Platinum-Based Adjuvant Therapy
por: Li, Yueyi, et al.
Publicado: (2022)

Impact of Histopathological Diagnosis with Ancillary Immunohistochemical Studies on Lung Cancer Subtypes Incidence and Survival: A Population-Based Study
por: Andrea, Bordoni, et al.
Publicado: (2011)

Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS-2 multicentre study
por: Suurmeijer, J Annelie, et al.
Publicado: (2022)

PD-L1 as a Prognostic Factor in Early-Stage Colon Carcinoma within the Immunohistochemical Molecular Subtype Classification
por: Azcue, Pablo, et al.
Publicado: (2021)

Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer
por: Kim, Ga-Eon, et al.
Publicado: (2014)

Contrast Enhancement on Cone-Beam Breast-CT for Discrimination of Breast Cancer Immunohistochemical Subtypes()()()
por: Uhlig, Johannes, et al.
Publicado: (2017)

Clustering Molecular Subtypes in Breast Cancer, Immunohistochemical Parameters and Risk of Axillary Nodal Involvement
por: Pereira, Augusto, et al.
Publicado: (2022)

Immunohistochemical Study of Bladder Cancer Molecular Subtypes and Their Association with PD-L1 Expression
por: Goutas, Dimitrios, et al.
Publicado: (2022)

El derecho civil a finales del siglo XX /
por: Martínez de Aguirre y Aldaz, Carlos
Publicado: (1991)

FOXQ1 is Differentially Expressed Across Breast Cancer Subtypes with Low Expression Associated with Poor Overall Survival
por: Elian, Fahed A, et al.
Publicado: (2021)

The Extent of Necrosis in Brain Metastases May Predict Subtypes of Primary Cancer and Overall Survival in Patients Receiving Craniotomy
por: Yoo, Jihwan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1n2vflefqpmgbolmv7funt6kap